PTER expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.374600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.480400E-01
Normal-vs-Stage2
5.309200E-01
Normal-vs-Stage3
5.296100E-03
Normal-vs-Stage4
5.210200E-01
Stage1-vs-Stage2
5.901000E-01
Stage1-vs-Stage3
1.799380E-01
Stage1-vs-Stage4
5.495800E-01
Stage2-vs-Stage3
1.303750E-01
Stage2-vs-Stage4
3.269000E-01
Stage3-vs-Stage4
1.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.176200E-01
Normal-vs-AfricanAmerican
9.876200E-01
Normal-vs-Asian
5.434600E-01
Caucasian-vs-AfricanAmerican
3.553600E-01
Caucasian-vs-Asian
9.495800E-01
AfricanAmerican-vs-Asian
4.547600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.326400E-01
Normal-vs-Female
6.325200E-01
Male-vs-Female
6.899000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.177800E-01
Normal-vs-Age(41-60Yrs)
6.216800E-01
Normal-vs-Age(61-80Yrs)
5.086400E-01
Normal-vs-Age(81-100Yrs)
6.078200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.956200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.384000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.662200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.514800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.052400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.797350E-01
Normal-vs-Daily Drinker
2.603200E-01
Normal-vs-Weekly Drinker
5.082400E-01
Normal-vs-Occasional Drinker
7.565800E-01
Normal-vs-Social Drinker
4.869000E-01
Non Drinker-vs-Daily Drinker
6.782200E-01
Non Drinker-vs-Weekly Drinker
9.439800E-01
Non Drinker-vs-Occasional Drinker
3.872600E-01
Non Drinker-vs-Social Drinker
5.979400E-01
Daily Drinker-vs-Weekly Drinker
8.688400E-01
Daily Drinker-vs-Occasional Drinker
2.823000E-01
Daily Drinker-vs-Social Drinker
4.814800E-01
Weekly Drinker-vs-Occasional Drinker
5.095000E-01
Weekly Drinker-vs-Social Drinker
7.229600E-01
Occasional Drinker-vs-Social Drinker
6.921400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.701500E-02
Normal-vs-Grade 2
8.800700E-03
Normal-vs-Grade 3
1.107540E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.300800E-01
Grade 1-vs-Grade 3
1.953760E-01
Grade 1-vs-Grade 4
2.701500E-02
Grade 2-vs-Grade 3
7.468400E-01
Grade 2-vs-Grade 4
8.800700E-03
Grade 3-vs-Grade 4
1.107540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.185400E-01
Normal-vs-NonDiabetic
3.575400E-01
Diabetic-vs-NonDiabetic
8.030800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.455800E-01
Normal-vs-NoPancreatitis
3.961200E-01
Pancreatitis-vs-NoPancreatitis
9.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.634400E-01
Normal-vs-N1
5.381000E-01
N0-vs-N1
9.764000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.556200E-01
Normal-vs-TP53-NonMutant
8.891600E-01
TP53-Mutant-vs-TP53-NonMutant
4.874400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
